The Clorox Company (NYSE:CLX) Shares Bought by Private Advisor Group LLC

Private Advisor Group LLC raised its holdings in The Clorox Company (NYSE:CLXFree Report) by 8.3% during the third quarter, HoldingsChannel reports. The firm owned 33,823 shares of the company’s stock after buying an additional 2,586 shares during the period. Private Advisor Group LLC’s holdings in Clorox were worth $4,433,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Schroder Investment Management Group grew its position in Clorox by 384.0% during the second quarter. Schroder Investment Management Group now owns 64,175 shares of the company’s stock worth $10,206,000 after buying an additional 50,917 shares during the period. Glass Jacobson Investment Advisors llc purchased a new stake in shares of Clorox in the second quarter valued at about $53,000. Latitude Advisors LLC purchased a new stake in shares of Clorox in the second quarter valued at about $215,000. Daiwa Securities Group Inc. lifted its holdings in shares of Clorox by 1.6% in the second quarter. Daiwa Securities Group Inc. now owns 9,709 shares of the company’s stock valued at $1,544,000 after purchasing an additional 157 shares in the last quarter. Finally, Jennison Associates LLC purchased a new position in shares of Clorox during the second quarter valued at approximately $1,862,000. 77.98% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.2 %

Clorox stock traded up $0.31 during trading hours on Friday, reaching $144.46. 458,325 shares of the company’s stock traded hands, compared to its average volume of 1,148,843. The company has a debt-to-equity ratio of 18.92, a quick ratio of 0.54 and a current ratio of 0.86. The firm has a market capitalization of $17.92 billion, a price-to-earnings ratio of 213.41, a PEG ratio of 2.93 and a beta of 0.41. The firm’s 50 day moving average is $142.15 and its 200-day moving average is $142.24. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Wednesday, November 1st. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.69. Clorox had a return on equity of 195.76% and a net margin of 1.22%. The business had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the prior year, the business earned $0.93 EPS. Clorox’s revenue for the quarter was down 20.3% compared to the same quarter last year. On average, analysts predict that The Clorox Company will post 4.57 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be given a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.32%. Clorox’s payout ratio is presently 705.89%.

Analysts Set New Price Targets

CLX has been the topic of a number of recent analyst reports. StockNews.com raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Thursday, December 7th. DA Davidson increased their price objective on shares of Clorox from $152.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, November 17th. Sanford C. Bernstein raised shares of Clorox from an “underperform” rating to a “market perform” rating and set a $120.00 price objective for the company in a research report on Thursday, October 12th. Raymond James lowered shares of Clorox from an “outperform” rating to a “market perform” rating in a research report on Thursday, October 5th. Finally, Evercore ISI dropped their price objective on shares of Clorox from $160.00 to $120.00 and set an “underperform” rating for the company in a research report on Thursday, October 5th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $142.13.

Get Our Latest Analysis on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.